SREBF1 and metabolic dysfunction-associated steatotic liver disease: Despite importance of SREBP1c in NAFLD, most studies have only concentrated on inhibiting the transcriptional activity of SREBP1c, and post-translational modifications of SREBP1c remains unclear.